International Business Times
This article examines the U.S. Supreme Court oral arguments on whether a class of GlaxoSmithKline pharmaceutical sales representatives is entitled to overtime pay. Littler’s Lee Schreter provides insight on the significance of this case and explains that it could have far-reaching impact not just for the pharmaceutical industry, but for any employer that has a sales force.
